DOP60 Simplified rules to identify bio-naïve patients with Crohn’s Disease with higher likelihood of clinical remission when initiating vedolizumab versus anti-TNFα therapies: Analysis of EVOLVE study dataGerassimos J. Mantzaris, Brian Bressler, Shu Wang et al.|Journal of Crohn s and Colitis|2021Cited by 7